These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30430949)

  • 21. Insulin resistance, neuroinflammation, and Alzheimer's disease.
    Najem D; Bamji-Mirza M; Chang N; Liu QY; Zhang W
    Rev Neurosci; 2014; 25(4):509-25. PubMed ID: 24622783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking insulin with Alzheimer's disease: emergence as type III diabetes.
    Ahmed S; Mahmood Z; Zahid S
    Neurol Sci; 2015 Oct; 36(10):1763-9. PubMed ID: 26248483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Review on Neuro-degenerative Type 3 DM.
    Chandarana CV; Roy S
    Curr Diabetes Rev; 2022; 18(8):e131221198790. PubMed ID: 34961464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
    Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease: Is this a brain specific diabetic condition?
    Rani V; Deshmukh R; Jaswal P; Kumar P; Bariwal J
    Physiol Behav; 2016 Oct; 164(Pt A):259-67. PubMed ID: 27235734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century.
    Rorbach-Dolata A; Piwowar A
    Biomed Res Int; 2019; 2019():1435276. PubMed ID: 31428627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.
    Sato N; Takeda S; Uchio-Yamada K; Ueda H; Fujisawa T; Rakugi H; Morishita R
    Curr Aging Sci; 2011 Jul; 4(2):118-27. PubMed ID: 21235496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
    Kroner Z
    Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology.
    Yang JJ
    Acta Neurol Belg; 2022 Oct; 122(5):1135-1142. PubMed ID: 35482277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets.
    Vieira MNN; Lima-Filho RAS; De Felice FG
    Neuropharmacology; 2018 Jul; 136(Pt B):160-171. PubMed ID: 29129775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.
    Morgen K; Frölich L
    J Neural Transm (Vienna); 2015 Apr; 122(4):499-504. PubMed ID: 25673434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
    Tumminia A; Vinciguerra F; Parisi M; Frittitta L
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    de la Monte SM; Tong M; Schiano I; Didsbury J
    J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.